Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study
Cardiovascular Research · 02.07.2024 · 120 (8) · 855-868
DOI: 10.1093/cvr/cvae067 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cardiovascular Research, online erschienen am 13.04.2024. Verfasst von Larissa Fabritz und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg,…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Biomarkers, Phenotype, Cardiometabolic Risk Factors. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Ministry of Education and Research, American Heart Association, CATCH-ME.
Abstract (Originalsprache)
Aims
Atrial fibrillation (AF) and concomitant cardiometabolic disease processes interact and combine to lead to adverse events, such as stroke, heart failure, myocardial infarction, and cardiovascular death. Circulating biomolecules provide quantifiable proxies for cardiometabolic disease processes. The aim of this study was to test whether biomolecule combinations can define phenotypes in patients with AF. Methods and results This pre-specified analysis of the EAST-AFNET 4 biomolecule study assigned patients to clusters using polytomous variable latent-class analysis based on baseline concentrations of 13 precisely quantified biomolecules potentially reflecting ageing, cardiac fibrosis, metabolic dysfunction, oxidative stress, cardiac load, endothelial dysfunction, and inflammation. In each cluster, rates of cardiovascular death, stroke, or hospitalization for heart failure or acute coronary syndrome, the primary outcome of EAST-AFNET 4, were calculated and compared between clusters over median 5.1 years follow-up. Findings were independently validated in a prospective cohort of 748 patients with AF (BBC-AF; median follow-up 2.9 years). Unsupervised biomolecule analysis assigned 1586 patients (71 years old, 46% women) into four clusters. The highest risk cluster was dominated by elevated bone morphogenetic protein 10, insulin-like growth factor–binding protein 7, N-terminal pro-B-type natriuretic peptide, angiopoietin 2, and growth differentiation factor 15. Patients in the lowest risk cluster showed low concentrations of these biomolecules. Two intermediate-risk clusters differed by high or low concentrations of C-reactive protein, interleukin-6, and D-dimer. Patients in the highest risk cluster had a five-fold higher cardiovascular event rate than patients in the low-risk cluster. Early rhythm control was effective across clusters (Pinteraction = 0.63). Sensitivity analyses and external validation in BBC-AF replicated clusters and risk gradients.
Conclusion
Biomolecule concentrations identify cardiometabolic subphenotypes in patients with AF at high and low cardiovascular risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
- University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Germany.
- AFNET, Münster, Germany.
- Institute of Cardiovascular Sciences, University of Birmingham, Wolfson Drive, Birmingham, UK.
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Larissa Fabritz, Winnie Chua, Victor R Cardoso, Christoph Al-Taie, Anna Suling, Linda Krause, Shinwan Kany, Christina Magnussen, Karl Wegscheider, Guenter Breithardt, Harry J G M Crijns, A John Camm, George Gkoutos, Patrick T Ellinor, Andreas Goette, Ulrich Schotten, Tanja Zeller, Antonia Zapf, Paulus Kirchhof
Förderung
- German Ministry of Education and Research
- American Heart Association
- CATCH-ME
- British Heart Foundation
- Leducq Foundation
- DZHK
- promotion of women scientists programme
- Dutch Heart Foundation
Zitieren
APA
Fabritz, L., Chua, W., Cardoso, V. R., Al-Taie, C., Borof, K., Suling, A., Krause, L., Kany, S., Magnussen, C., Wegscheider, K., Breithardt, G., Crijns, H. J. G. M., Camm, A. J., Gkoutos, G., Ellinor, P. T., Goette, A., Schotten, U., Wienhues-Thelen, U. H., Zeller, T., …, & Kirchhof, P. (2024). Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study. Cardiovascular Research, 120(8), 855-868. https://doi.org/10.1093/cvr/cvae067
Vancouver
Fabritz L, Chua W, Cardoso VR, Al-Taie C, Borof K, Suling A, et al. Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study. Cardiovascular Research. 2024;120(8):855-868. doi:10.1093/cvr/cvae067
BibTeX
@article{Fabritz2024,
author = {Fabritz, Larissa and Chua, Winnie and Cardoso, Victor R and Al-Taie, Christoph and Borof, Katrin and Suling, Anna and Krause, Linda and Kany, Shinwan and Magnussen, Christina and Wegscheider, Karl and Breithardt, Guenter and Crijns, Harry J G M and Camm, A John and Gkoutos, George and Ellinor, Patrick T and Goette, Andreas and Schotten, Ulrich and Wienhues-Thelen, Ursula-Henrike and Zeller, Tanja and Schnabel, Renate B and Zapf, Antonia and Kirchhof, Paulus},
title = {Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {8},
pages = {855--868},
doi = {10.1093/cvr/cvae067}
}
EUVIMED